4//SEC Filing
Cardama Alfonso Quintas 4
Accession 0000899243-22-039033
CIK 0001750019other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:44 PM ET
Size
8.6 KB
Accession
0000899243-22-039033
Insider Transaction Report
Form 4
Cardama Alfonso Quintas
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit (Right to Buy)
2022-12-15+11,775→ 11,775 total→ Common Stock (11,775 underlying) - Award
Stock Option (Right to Buy)
2022-12-15+70,649→ 70,649 totalExercise: $0.97Exp: 2032-12-14→ Common Stock (70,649 underlying)
Holdings
- 109,459
Common Stock
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- [F3]The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
Related Parties
1- filerCIK 0001760104
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:44 PM ET
- Size
- 8.6 KB